Benchmark Litigation has shortlisted Williams & Connolly for its 2023 “Products Liability Firm of the Year” award. The firm’s Products Liability practice consistently receives recognition from top legal media ranking publications including Chambers, The Legal 500, and The National Law Journal.
Exemplifying the strength of our practice, the firm’s clients recently scored major victories at both the trial and appellate levels.* In December 2022, Williams & Connolly secured a major Daubert and summary judgment victory on behalf of Pfizer in the closely-watched Zantac® products liability multidistrict litigation, effectively ending one of the largest personal injury MDLs in U.S. history. And in January 2023, Williams & Connolly secured the U.S. Court of Appeals for the First Circuit’s unanimous affirmance of summary judgment for GlaxoSmithKline in multidistrict product liability litigation concerning Zofran®, an anti-nausea medication.
Click here to see the full list of Benchmark Litigation’s shortlisted firms.
* All cases vary and none is predictive.